Spots Global Cancer Trial Database for ctcs
Every month we try and update this database with for ctcs cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients | NCT02997709 | Prostate Cancer | 30 Years - | University of Miami | ||
Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² Study | NCT06105177 | Lung Cancer | 18 Years - | Catharina Ziekenhuis Eindhoven | ||
Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Lung and Head and Neck Cancers | NCT05091190 | Metastatic NSCL... Metastatic Head... | Blood draws | 18 Years - | Hospices Civils de Lyon | |
Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² Study | NCT06105177 | Lung Cancer | 18 Years - | Catharina Ziekenhuis Eindhoven | ||
NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy" | NCT03771404 | Non Small Cell ... | blood sampling | 18 Years - | Hellenic Oncology Research Group | |
NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy" | NCT03771404 | Non Small Cell ... | blood sampling | 18 Years - | Hellenic Oncology Research Group | |
Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients | NCT02626039 | Metastatic Brea... | 18 Years - | Hospital General Universitario Gregorio Marañon | ||
NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy" | NCT03771404 | Non Small Cell ... | blood sampling | 18 Years - | Hellenic Oncology Research Group | |
Change of Circulating Tumor Cells During Laparoscopic or Transanal Endoscopic Surgery for Rectal Cancer. | NCT05109130 | Rectal Neoplasm... Neoplastic Cell... Laparoscopic Su... Transanal Endos... | Surgical approa... | 18 Years - | Sun Yat-sen University | |
Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer | NCT00429182 | Breast Cancer Metastatic Brea... Invasive Breast... | Carboplatin Cyclophosphamid... Thiotepa Stem Cell Trans... | 18 Years - 55 Years | M.D. Anderson Cancer Center | |
NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy" | NCT03771404 | Non Small Cell ... | blood sampling | 18 Years - | Hellenic Oncology Research Group | |
Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Lung and Head and Neck Cancers | NCT05091190 | Metastatic NSCL... Metastatic Head... | Blood draws | 18 Years - | Hospices Civils de Lyon | |
Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients | NCT01129336 | First or Second... Metastatic Dise... | Zoledronic acid Standard Therap... | 18 Years - | Novartis | |
Clinical Application of an Automated Liquid Biopsy Platform for Early Detection of Colorectal Cancer | NCT03476122 | Colo-rectal Can... | 20 Years - | CellMaxLife | ||
Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients | NCT02626039 | Metastatic Brea... | 18 Years - | Hospital General Universitario Gregorio Marañon | ||
Clinical Application of an Automated Liquid Biopsy Platform for Early Detection of Colorectal Cancer | NCT03476122 | Colo-rectal Can... | 20 Years - | CellMaxLife | ||
The Expression of ZEB1 in CTCs Associated With Metastasis and Recurrence for Gastric Cancer | NCT02431078 | Stomach Neoplas... | Routine compreh... | 18 Years - 80 Years | Chinese PLA General Hospital | |
Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients | NCT01129336 | First or Second... Metastatic Dise... | Zoledronic acid Standard Therap... | 18 Years - | Novartis | |
Evaluation of CTCs Combined With Tumor Marker Detection of Efficacy of Chemotherapy in mCRC | NCT02948985 | Colorectal Canc... | treated with FO... | 18 Years - 75 Years | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | |
The Establishment and Clinical Application of a Prediction Model of Lung Cancer Distant Metastasis Based on the Genomic Characteristics of Circulating Tumor Cells | NCT04568720 | Lung Cancer CTCs | blood sample | 18 Years - 75 Years | Chinese Medical Association | |
Diagnostic Power Comparison Between VOCs and CTCs | NCT03958812 | Circulating Tum... Volatile Organi... Breast Cancer Gastric Cancer Diagnoses Disea... | Circulating tum... | 18 Years - 75 Years | Anhui Medical University |